Takeda’s shareholders are urging the company to put its $62 billion acquisition of Shire to a vote.
Lumendi received FDA 510(k) clearance for the DiLumen Is Endolumenal Interventional Scissors.
Motus GI enrolled the first patient into its reliable endoscopic diagnosis utilizing cleansing enhancement, or REDUCE, study that’ll test the ability of the Pure-Vu System to properly prepare bowels for a diagnostic colonoscopy procedure.
Prescient Surgical’s novel wound retractor CleanCision is associated with reduced bacterial contamination in colorectal surgery.
More articles on gastroenterology:
After 47-year moratorium, Massachusetts has 1st new ASC — 5 insights
3 ASCs, Cigna settle alleged ERISA violation suit
Healthcare Re, Muve Health roll out 1st prospective bundle reinsurance policy
